Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers January 20, 2019
Pharmacy Choice - News - Drug Delivery Systems - January 20, 2019

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 87     Next >>     Go To Page:

1/19/19 - Drug Delivery Device [TendersInfo (India)]
National procurement notice: drug delivery device. The acquisition is aimed at the acquisition of a hospital drugstore for the east savo hospital district, which includes a machine-powered dosage dispenser, a system for controlling the dose dispenser, a system for ordering and recording patient-specific drugs, and maintenance services. a more detai
1/19/19 - Drug Delivery Systems Marketto Reach Approximately US $900 Bn by 2025
Albany, NY 01/19/2019 Transparency Market Research has published a new report titled " Drug Delivery System Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 2025". Key players introduce new drugs delivery systems and devices in developed markets such a North America and Western Europe. Rise in R&D investmen
1/19/19 - Top Factors Driving the Connected Drug Delivery Devices Market to 2027 : OPKO Health Inc., Bayer AG, 3M Company: German consumers willingness to invest in their well-being and fast data networks is providing fertile ground for mHealth and connecte
Valley Cottage, NY 01/19/2019 The market for connected drug delivery devices is foreseen to witness a stellar growth rate of 25.6% from 2015 to 2027 rising to a valuation of US$ 1,304.7 Mn from US$ 132.2 Mn in 2017. According to the analyst of Future Market Insights, the leading manufacturers of connected drug delivery devices are focusing co
1/18/19 - Advanced Drug Delivery Systems Market 2019- Global Industry Analysis, By Key Players, Segmentation And Forecast By 2025
Advanced Drug Delivery Systems- Global Market Growth, Opportunities, Analysis Of Top Key Players And Forecast To 2025. Advanced Drug Delivery Systems Market 2019. Regionally, this report categorizes the production, apparent consumption, export and import of Advanced Drug Delivery Systems in North America, Europe, China, Japan, Southeast Asia and In
1/18/19 - Delivery Of Equipment Under Work Package 8 - Drug-delivery Systems For Directional Action Of Drugs And Personalized Medicine For Medical University - Plovdiv By Lot [TendersInfo (India)]
Contract notice: Delivery of equipment under work package 8- "drug-delivery systems for directional action of drugs and personalized medicine" for medical university- plovdiv by lot. Estimated total value Value excluding VAT: 2 926 699.22 BGN. This contract is divided into lots: Yes.
1/18/19 - Drug Delivery Systems Marketto Reach Approximately US $900 Bn by 2025-End
Albany, NY 01/17/2019 Drug delivery includes formulations, technologies, methods, and systems for transferring an active pharmaceutical ingredients into the body to safely provide therapeutic effect. The global Drug Delivery Systems Market was valued approximately US$ 510 Bn in 2016 and is anticipated to expand at a CAGR of over 6.9% from 201
1/18/19 - Luye Pharma Reaches Strategic Partnership with AstraZeneca, Strengthens Commitment to Cardiovascular Therapeutic Field
Luye Pharma has announced it has entered an agreement with AstraZeneca China, the terms of which grant AstraZeneca China exclusive rights to promote Luye Pharma's Xuezhikang Capsules in mainland China. According to the agreement, AstraZeneca will be responsible for the exclusive promotion of Xuezhikang Capsules in mainland China, while Luye Pharma
1/18/19 - Medtronic Enrolls First Patient in Clinical Study to Assess Pain Control and Oral Opioid Elimination with Targeted Drug Delivery
DUBLIN- Medtronic plc today announced the first patient enrolled in the Embrace TDD clinical study that will evaluate the use of the SynchroMed II intrathecal drug delivery system as an alternative to oral opioids for patients with chronic intractable non-malignant primary back pain with or without leg pain. The first patient was enrolled by John A
1/18/19 - Medtronic Enrolls First Patient in Clinical Study to Assess Pain Control and Oral Opioid Elimination with Targeted Drug Delivery [Syrian Arab News Agency]
Medtronic plc today announced the first patient enrolled in the Embrace TDD clinical study that will evaluate the use of the SynchroMed (TM) II intrathecal drug delivery system as an alternative to oral opioids for patients with chronic intractable non-malignant primary back pain with or without leg pain. The first patient was enrolled by John A. H
1/18/19 - Medtronic Enrolls First Patient in Clinical Study to Assess Pain Control and Oral Opioid Elimination with Targeted Drug Delivery [Tehran Times (Iran)]
DUBLIN- January 17, 2019- Medtronic plc today announced the first patient enrolled in the Embrace TDD clinical study that will evaluate the use of the SynchroMed (TM) II intrathecal drug delivery system as an alternative to oral opioids for patients with chronic intractable non-malignant primary back pain with or without leg pain. The first patient
1/18/19 - Sino Biopharma (01177) gets anti-tumour drug approval [ET Net News (China)]
that Lenalidomide Capsule, an anti-tumour drug developed by Chia-Tai Tianqing. Pharmaceutical Holdings Co. Ltd., a subsidiary of the company, has obtained approval for. drug registration by the National Medical Products Administration of the People's Republic.
1/18/19 - Tris Pharma to Present Three Posters Covering Data on Dyanavel XR and Tris' LiquiXR Technology at the 2019 APSARD Annual Meeting
MONMOUTH JUNCTION- Tris Pharma, Inc., a biopharmaceutical company focused on developing innovative products that deliver meaningful patient benefits, today announced that it will present information on its proprietary drug delivery platform LiquiXR as well as data from two clinical studies on DYANAVEL XR extended-release oral suspension, CII, at th
1/17/19 - A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CDX-6114 Following Single, Ascending Oral Dose Administration to Healthy Volunteers
By a News Reporter-Staff News Editor at Clinical Trials Week Staff editors report on the newly launched clinical trial, NCT03797664, which has the following summary description: "The purpose of this study is to assess the safety and tolerability of an oral solution of CDX-6114 when administered as a single dose in healthy volunteers". As a matter
1/17/19 - A Randomized, Open-Label, Two-Treatment, Two-Period, Two-Way Crossover Study to Investigate the Relative Bioavailability of Entrectinib Capsule Formulations F1 and F06 Under Fed Conditions in Healthy Subjects
By a News Reporter-Staff News Editor at Pharma Business Week Staff editors report on the newly launched clinical trial, NCT03796260, which has the following summary description: "This study aims to investigate the relative bioavailability, safety, and tolerability of entrectinib capsule formulations F1 and F06 under fed conditions in healthy adul
1/17/19 - Adamis Commercial Partner Launches SYMJEPI (epinephrine) in the US [Syrian Arab News Agency]
-Adamis Pharmaceuticals Corporation today announced that its marketing and commercial partner, Sandoz Inc., a Novartis division, has launched SYMJEPI 0.3 mg Injection in the US market for the emergency treatment of allergic reactions, including anaphylaxis. Sandoz is launching this medicine as an affordable, single-dose, pre-filled syringe alternat
1/17/19 - Adamis' Commercial Partner Launches SYMJEPI in the US
SAN DIEGO- Adamis Pharmaceuticals Corporation today announced that its marketing and commercial partner, Sandoz Inc., a Novartis division, has launched SYMJEPI 0.3 mg Injection in the US market for the emergency treatment of allergic reactions, including anaphylaxis. Sandoz is launching this medicine as an affordable, single-dose, pre-filled syring
1/17/19 - Amgen Makes All Repatha evolocumab Device Options Available In The US At A 60 Percent Reduced List Price
By a News Reporter-Staff News Editor at Managed Care Weekly Digest Amgen announced that as part of the Company's commitment to improve patient affordability for an innovative biologic medicine for people with high cholesterol who are at risk for heart attacks and strokes, all Repatha device options, including the Pre-Filled Syringe and Pushtro
1/17/19 - Amring Pharmaceuticals Announces 2018/19 Launches
By a News Reporter-Staff News Editor at Drug Week Amring Pharmaceuticals Inc., a generic pharmaceutical and ophthalmic medical device company, announced that it launched a generic oncology drug, Arsenic Trioxide Injection in November 2018 and expects to launch four additional generic drugs in 2019. Amring Pharmaceuticals is a privately-held gener
1/17/19 - Data on Drug Delivery Systems Described by A. Bernkop-Schnurch et al (Strategies to overcome the polycation dilemma in drug delivery)
By a News Reporter-Staff News Editor at Cancer Gene Therapy Week Investigators publish new report on Drugs and Therapies- Drug Delivery Systems. According to news reporting from Innsbruck, Austria, by NewsRx editors, the research stated, "Because of polycationic auxiliary agents such as chitosan, polyethyleneimine and cell penetrating peptides as
1/17/19 - Data on Drug Delivery Systems Described by F.A. Maulvi et al (Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies)
By a News Reporter-Staff News Editor at Drug Week Data detailed on Drugs and Therapies- Drug Delivery Systems have been presented. According to news originating from Gujarat, India, by NewsRx correspondents, research stated, "The aim of the present research work was to formulate, optimize and evaluate the in-situ gel for the ophthalmic drug deliv
1/17/19 - Diabetes Care Devices Market 2019: Current Competitive Scenario, Challenges and Forecast To 2025 By BD, Roche, Johnson & Johnson, Bayer, Abbott, Medtronic, ACON Laboratories and More
Data Bridge Market Research provides new industry report "Global Diabetes Care Devices Market" accounted to USD 25 billion in 2016 growing at a CAGR of 8.0% during the forecast period of 2017 to 2024.. Global Diabetes Care Devices Market, By Product Type (Blood glucose monitoring devices (testing strips, self-monitoring blood glucose meters, lancet
1/17/19 - Drug Delivery Devices Market 2019- Global Industry Analysis, By Key Players, Segmentation, Trends And Forecast By 2025
Drug Delivery Devices- Global Market Growth, Opportunities, Analysis Of Top Key Players And Forecast To 2025. Drug Delivery Devices Market 2019. Regionally, this report categorizes the production, apparent consumption, export and import of Drug Delivery Devices in North America, Europe, China, Japan, Southeast Asia and India.
1/17/19 - Drug-Loaded Oral Thin Films Market Foraying Into Emerging Economies 2018 to 2026
Rockville, MD 01/16/2019 The oral route for drug administration takes up more than 50% of the available drug in the market. Drug-loaded oral thin films have composed drug quantity that is administered via mouth. The composition of drug-loaded oral thin films not only require API but need supporting biocompatible ingredients such as strip form
1/17/19 - FDA approves first generic version of Sabril to help treat seizures in adults and pediatric patients with epilepsy
The U.S. Food and Drug Administration approved the first generic version of Sabril 500 mg tablets for treating complex partial seizures, also called focal seizures, as an adjunctive therapy in patients 10 years and older who have responded inadequately to several alternative treatments. 'Prioritizing the approval of generic drugs to compete with me
1/17/19 - Findings from G.R. Williams and Co-Researchers Advance Knowledge in Drug Delivery Systems (Functionalized MoS2-nanosheets for targeted drug delivery and chemo-photothermal therapy)
By a News Reporter-Staff News Editor at Cancer Weekly Current study results on Drugs and Therapies- Drug Delivery Systems have been published. Financial supporters for this research include Shanghai Municipal Science and Technology Commission Project, Biomedical Textile Materials "111 Project" of the China Ministry of Education, UK-China Joint...
Articles(s): 1 - 25 of 87     Next >>     Go To Page:


© 2019 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415